Mantle Cell Lymphoma News

News

Survival Outcomes Among Patients With Mantle Cell Lymphoma Treated With Bruton Tyrosine Kinase Inhibitors

03/29/2022

Marta Rybczynski

A population-based cohort analysis on patients who were diagnosed with mantle cell lymphoma found that overall survival and lymphoma-specific survival may improve with BTK inhibitors.

A population-based cohort...

03/29/2022

Journal of Clinical Pathways

News

Treatment Landscape for Newly Diagnosed and Relapsed/Refractory MCL

03/15/2022

Janelle Bradley

A review published in Therapeutic Advances in Hematology summarized the treatment landscape of newly diagnosed and relapsed and refractory MCL.

A review published in...

03/15/2022

Journal of Clinical Pathways

News

Leading Organizations Release Clinical Practice Guidelines for Transplantation and Cellular Therapies in MCL

03/01/2022

Janelle Bradley

A panel convened by leading organizations formulated recommendations for role, timing, and sequencing of blood and bone marrow transplantation and CAR-T therapy for newly diagnosed and relapsed/refractory MCL.

A panel convened by leading...

03/01/2022

Journal of Clinical Pathways

News

Long-term Survival After Autologous Transplantation Among Patients With MCL

02/23/2022

Janelle Bradley

Study findings confirm the long-term efficacy of autologous hematopoietic stem cell transplantation for treating MCL.

Study findings confirm the...

02/23/2022

Journal of Clinical Pathways

News

Cost Analysis of Intravenous vs Subcutaneous Rituximab for Patients With NHL

02/18/2022

Marta Rybczynski

Study findings suggest a 20% transition from intravenous to subcutaneous rituximab for patients with NHL has the potential to generate significant US health system value in the form of payer savings, increased practice capacity, and patient...

Study findings suggest a 20%...

02/18/2022

Journal of Clinical Pathways

News

Changes in Frontline Therapy Associated With Improved Survival Outcomes Among Patients With MCL

02/18/2022

Marta Rybczynski

Study findings provide real-world evidence for improved outcomes with the evolving frontline pattern of care in patients with MCL.

Study findings provide...

02/18/2022

Journal of Clinical Pathways

News

Treatment Patterns and Outcomes in Older Patients with MCL

06/02/2021

Study findings suggest that older patients with MCL may not benefit from maintenance rituximab due to an inability to tolerate this treatment.

Study findings suggest that...

06/02/2021

Journal of Clinical Pathways

News

Real-World Health Care Burden Among Medicare Patients With MCL

05/26/2021

Journal of Clinical Pathways

News

Cost-Effectiveness of KTE-X19 vs Standard of Care for Relapsed/Refractory MCL

03/16/2021

Journal of Clinical Pathways

News

Real-World Practice Patterns, Comorbidities in Medicare Patients With MCL

01/21/2021

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Mantle Cell Lymphoma News

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products